Skip to main content
. 2018 Feb 28;14(2):191–199. doi: 10.3988/jcn.2018.14.2.191

Table 2. Patient characteristics for variables that were measured longitudinally.

Variables Overall (n=816) Institutionalized (n=130, 16.0%) Not institutionalized (n=686, 84.0%) p
Age (year) 73.3±7.9 74.1±8.2 73.2±7.9 0.21
Female 279 (34.2) 42 (32.3) 237 (24.6) 0.62
Education (year) 6.7±5.2 6.2±5.1 6.8±5.2 0.19
Duration from onset to diagnosis (month) 33.0±30.8 31.2±24.6 33.3±31.8 0.39
Dementia severity and clinical variables
 Annual MMSE score change −1.8±4.5 −2.9±4.7 −1.6±4.4 <0.01*
 Annual CDR-SB score change 1.9±3.1 3.5±3.9 1.6±2.9 <0.01*
 Annual NPI score change 1.8±18.0 4.2±22.0 1.4±17.1 0.18
GDS score 6.7±4.3 6.6±4.5 6.8±4.3 0.64
Comorbidities
 Hypertension 411 (50.4) 61 (46.9) 350 (51.0) 0.39
 Diabetes mellitus 187 (22.9) 34 (26.2) 153 (22.3) 0.33
 Cardiovascular disease 121 (14.8) 18 (13.9) 103 (15.0) 0.73
 Stroke 62 (7.6) 10 (7.7) 52 (7.6) 0.96
Alcohol consumption 0.05
 Current 515 (79.7) 96 (86.5) 419 (78.3)
 Never 131 (20.3) 15 (13.5) 116 (21.7)
Smoking 0.56
 Current smoker 56 (8.7) 7 (6.3) 49 (9.2)
 Ex-smoker 123 (19.0) 20 (18.0) 103 (19.3)
 Never smoked 467 (72.3) 84 (75.7) 383 (71.6)
Living with main caregiver 490 (60.2) 72 (55.8) 418 (61.0) 0.26
Medication usage (MPR)
 Antipsychotics 0.2±0.4 0.4±0.4 0.2±0.3 <0.01*
 Benzodiazepines 0.3±0.4 0.3±0.4 0.3±0.4 0.80
 Galantamine 0.3±0.4 0.3±0.4 0.3±0.4 0.77
 Rivastigmine 0.4±0.4 0.4±0.4 0.4±0.4 0.92
 Donepezil 0.6±0.4 0.6±0.4 0.6±0.4 0.48
 Memantine 0.2±0.3 0.3±0.4 0.2±0.3 0.05

Data are mean±standard-deviation or n (%) values.

*p<0.05 between institutionalized and not-institutionalized patients.

CDR-SB: Clinical Dementia Rating Sum of Boxes, GDS: Geriatric Depression Scale, MMSE: Mini Mental State Examination, MPR: medication possession ratio, NPI: NeuroPsychiatric Inventory.